Paper I
Question
Laboratory diagnosis of acute promyelocytic leukemia.
Answer
Acute promyelocytic leukaemia (APL) is a distinct subtype of AML (AML-M3 in the older FAB classification).
Peripheral blood/bone marrow morphology
- Abnormal promyelocytes with heavy azurophilic granulation
- Bundles of Auer rods in the cytoplasm (“faggot cells”) — characteristic finding
- Bilobed/reniform nuclei
Cytogenetics
- Characteristic reciprocal translocation t(15;17)(q22;q12), fusing the PML gene (chromosome 15) with the RARA (retinoic acid receptor alpha) gene (chromosome 17), producing the PML-RARA fusion protein — confirmed by FISH or RT-PCR
Immunophenotyping (flow cytometry)
- Positive for myeloid markers (CD13, CD33, MPO)
- Characteristically negative or dim for HLA-DR and CD34 (helps distinguish from other AML subtypes)
Coagulation studies
- Screening for disseminated intravascular coagulation (DIC) — a critical and often presenting complication of APL: prolonged PT/aPTT, low fibrinogen, elevated D-dimer/fibrin degradation products, thrombocytopenia
Clinical significance
- Prompt recognition is essential because APL is uniquely sensitive to all-trans retinoic acid (ATRA), which induces differentiation of the malignant promyelocytes, and because of the high risk of fatal haemorrhage from DIC if treatment is delayed

